Tomasz Beer, MD
Enriched profileChief Medical Officer for Multi-Cancer Early Detection, Exact Sciences; Adjunct Professor of Medicine, OHSU Knight Cancer Institute · Exact Sciences Corporation
Tomasz Beer is Chief Medical Officer for Multi-Cancer Early Detection, Exact Sciences; Adjunct Professor of Medicine, OHSU Knight Cancer Institute at Exact Sciences Corporation. OpenAlex indexes 788 publications with 38,586 citations (h-index 81); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Tomasz Beer, MD, is Chief Medical Officer for Multi-Cancer Early Detection, Exact Sciences at Exact Sciences Corporation. The public record shows 788 publications with 38,586 citations (h-index 81), centered on Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Bone health and treatments. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2000–2009).
- Top research focus: Prostate Cancer Treatment and Research
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 30 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 283.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- Falcon Real World Evidence Registry
Sponsor: Exact Sciences Corporation
- Pre-Prostatectomy Celecoxib or Placebo
Sponsor: OHSU Knight Cancer Institute
- Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
Sponsor: OHSU Knight Cancer Institute
Industry payments
Updated 16 Oct 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20252 payments
- AstraZeneca UK LimitedProgram year20243 payments
- PFIZER INC.Program year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
91.7%Androgen Receptor Inhibitor38.1%Xtandi77%Bicalutamide23%Part D<11 patientsCytochrome P450 17A1 Inhibitor27.9%Abiraterone Acetate100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
8.3%Corticosteroid8.3%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
8 NIH research awards on record, funded 2000–2009 per NIH RePORTER. The latest:
- Resistance and Response Mechanisms to Prostate Cancer Therapy
Oregon Health & Science University
FY2009$337,853R01CA119125 - Resistance and Response Mechanisms to Prostate Cancer Therapy
Oregon Health & Science University
FY2008$340,148R01CA119125
Congress activity
Updated 16 Oct 2026
187 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Abstract 1108: Performance of an optimized methylation-protein multi-cancer early detection (MCED) test classifier
AACR Annual Meeting
AACR2026Co-author - Abstract 1109: The complementary contributions of methylation and protein biomarker classes in a multi-cancer early detection (MCED) test
AACR Annual Meeting
AACR2026Co-author - Beyond detection: Five-year screening behaviors and patient-reported perceptions in DETECT-A participants.
ASCO Annual Meeting
ASCO2026Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine
2021
Most-cited works
by citation count (OpenAlex)- 01Enzalutamide in Metastatic Prostate Cancer before ChemotherapyArticle3,026 citations2014
- 02Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate CancerArticle2,824 citations2021
- 03Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerArticle2,283 citations2009
- 04
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tomasz-beer-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
hlth.com/speakers/2024/tomasz-beer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hlth.com ↗ - Other
milkeninstitute.org/events/future-health-summit-2023/speakers/tomasz-beer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →milkeninstitute.org ↗ - Other
pmwcintl.com/speaker/tom-beer-248_exact-sciences_2025sv
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmwcintl.com ↗ - Other
audible.de/podcast/Ep-404-The-Promise-The-Potential-and-the-Pressing-Questions-Facing-Multi-Cancer-Early-Detection-MCED-Testing-Tom-Beer-MD/B0GWS4PLNQ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →audible.de ↗ - Other
expertinstitute.com/experts/dr-tomasz-michal-beer-68887
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertinstitute.com ↗ - Other
ohsu.edu/people/tomasz-m-beer-md-facp
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →exactsciences.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
Awards & honors
honors on the public record- Fellow
American College of Physicians (FACP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor of Medicine
OHSU Knight Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →milkeninstitute.org ↗
- Podcast appearance: 'The Promise
The Potential and the Pressing Questions Facing Multi-Cancer Early Detection (MCED) Testing'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →audible.de ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →insideprecisionmedicine.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →personalizedmedicineconference.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)